ConductScience.org, home

Paper166286

Beta-lactamase (Bacillus cereus).

Thatcher DR. Methods Enzymol, 1975. Cited by 15 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Beta-lactamase (Bacillus cereus). Papers, record 166286. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/166286

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Beta-lactamase (Bacillus cereus).
PubMed
Journal
Methods Enzymol
PubMed
Year
1975
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
0.55
iCite
Revised in PubMed
2019-07-11
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Thatcher DRD R

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AmidohydrolasesMajor topic
Bacillus cereusMajor topic
CephalosporinaseMajor topic
PenicillinaseMajor topic
Amino Acids
Chromatography
Chromatography, Ion Exchange
Drug Stability
Kinetics
Methods
Molecular Weight
Penicillin G
Protein Conformation
Silicon Dioxide
Structure-Activity Relationship

Source PubMed

Download CSV of topics

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
8471035An overview of the kinetic parameters of class B beta-lactamases.Biochem J1993https://conductscience.org/library/papers/8471035PubMed
7035856Antibiotic resistance in pathogenic and producing bacteria, with special reference to beta-lactam antibiotics.Microbiol Rev1981https://conductscience.org/library/papers/7035856PubMed
6781486Production of a variant of beta-lactamase II with selectively decreased cephalosporinase activity by a mutant of Bacillus cereus 569/H/9.Biochem J1980https://conductscience.org/library/papers/6781486PubMed
6246876Inhibition of beta-lactamase of Bacillus licheniformis 749/C by compound PS-5, a new beta-lactam antibiotic.Biochem J1980https://conductscience.org/library/papers/6246876PubMed
3530127Lincomycin stimulates synthesis of TEM-2 beta-lactamase by Escherichia coli.Antimicrob Agents Chemother1986https://conductscience.org/library/papers/3530127PubMed
2537624Unexpected influence of ionic strength on branched-pathway interactions between beta-lactamases and beta-halogenopenicillanates.Biochem J1989https://conductscience.org/library/papers/2537624PubMed
314287Identification of histidine residues that act as zinc ligands in beta-lactamase II by differential tritium exchange.Biochem J1979https://conductscience.org/library/papers/314287PubMed
33655Histidine residues of zinc ligands in beta-lactamase II.Biochem J1978https://conductscience.org/library/papers/33655PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/166286

GET https://conductscience.org/api/papers/v1/166286/authors